DX600 TFA is a selective ACE2 specific inhibitor (KD: 1.3 nM), and does not cross-react with ACE. DX600 TFA exacerbates diabetes-induced cardiovascular dysfunction and the increase in cardiac and renal NOX activity[1][2][3].
Molecular Weight:
3074.33 (free acid)
Purity:
99.20
Formula:
C141H185N35O40S2.xC2HF3O2
Target:
Angiotensin-converting Enzyme (ACE)
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
